insights_auto
Outlook: 72.7% bullish·0.0% bearish
Go to analysischevron_right
EW:NYSE
Edwards Lifesciences Corp
$85.78
arrow_downward
-0.80%(-0.69) 1D
$85.78
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 7, 4:00:06 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$86.65
High
$87.30
Low
$85.49
Mkt. cap
49.44B
Avg. vol.
3.26M
Volume
3.51M
P/E ratio
49.63
52-wk high
$96.29
52-wk low
$72.30
EPS
$1.73
Beta
0.87
Shares outstanding
576.40M
No. of employees
16K
Open
$86.65
High
$87.30
Low
$85.49
Mkt. cap
49.44B
Avg. vol.
3.26M
Volume
3.51M
P/E ratio
49.63
52-wk high
$96.29
52-wk low
$72.30
EPS
$1.73
Beta
0.87
Shares outstanding
576.40M
No. of employees
16K
News stories
From web sources and news partners
The National Law Review
·
11 hours ago
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
Simply Wall Street
·
14 hours ago
Did FDA Approval Just Shift Edwards Lifesciences (EW) Investment Narrative?
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Websiteedwards.com